# Allogeneic Umbilical Cord Mesenchymal Stromal Cells for the Treatment of Chronic Antibody-Mediated Rejection in Kidney Transplantation

> **NCT06886646** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 22 (estimated)

## Conditions studied

- Chronic Antibody-mediated Rejection (cABMR)

## Interventions

- **OTHER:** Allogeneic Mesenchymal Stromal Cell Therapy
- **OTHER:** Placebo (NaCl 0.9%) Treatment

## Key facts

- **NCT ID:** NCT06886646
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-09-15
- **Primary completion:** 2027-09-15
- **Final completion:** 2029-10-15
- **Target enrollment:** 22 (ESTIMATED)
- **Last updated:** 2025-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06886646

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06886646, "Allogeneic Umbilical Cord Mesenchymal Stromal Cells for the Treatment of Chronic Antibody-Mediated Rejection in Kidney Transplantation". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT06886646. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*